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[571 ABSTRAm 
Method for the quick determination of the susceptibili- 
ties of various unidentified bacteria contained in an 
aqueous physiological fluid sample, particularly urine, 
to one or more antibiotics. A bacterial adenosine tri- 
phosphate (ATP) assay is carried out after the elimina- 
tion of non-bacterial ATP to determine whether an 
infection exists. If an infection does exist, a portion of 
the sample is further processed, including subjecting 
parts of the portion to one or more antibiotics. Growth 
of the bacteria in the parts are determined, again by an 
ATP assay, to determine whether the unidentified bac- 
teria in the sample are susceptible to the antibiotic or 
antibiotics under test. 
21 Claims, No Drawings 
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DETERMINATION OF ANTIMICROBIAL 
SUSCEPTIBUFFIES ON URINES 
WITHOUT ISOLATION 
ORIGIN OF THE INVENTION 
The invention described herein was made in the per- 
formance of work under a NASA contract and by em- 
ployees of the United States Government and is subject 
to the provisions of Section 305 of the National Aero- 
nautics and Space Act of 1958, Public Law 85-568 (72 
Stat. 435; 42 USC 2457), and may be manufactured and 
used by or for the Government for governmental pur- 
poses without the payment of any royalties thereon or 
therefor. 
BACKGROUND OF THE INVENTION 
The present invention relates generally to a method 
for determining the effectiveness of antimicrobial 
agents against bacteria. More particularly, the invention 
relates to a method for rapidly determining the effec- 
tiveness of antimicrobial agents against bacteria in phys- 
iological fluids. 
A rapid and routine procedure for the determination 
of the effectiveness of known antimicrobial agents 
against various bacteria is very frequently of vital im- 
portance, particularly for the measurement of the effec- 
tiveness of antimicrobial agents against bacteria in phys- 
iological fluids such as urine. Present techniques for the 
determination of microbial susceptibility generally re- 
quire at least overnight incubation of an infecting or- 
ganism after it is first isolated and cultured. The prior 
art techniques, therefore, require a waiting period of 
two days because of the double culture requirement to 
test the effectiveness of antimicrobial agents after the 
fluid specimen is received for testing. 
The most commonly used conventional techniques 
for the determination of microbial susceptibility to anti- 
microbial agents include agar diffusion (the Kirby- 
Bauer technique), broth dilution (Mic-Broth Dilution) 
and agar dilution. A long standing need continues to 
exist in practice for a rapid technique for determining 
microbial sensitivity to antimicrobial agents. A testing 
procedure is desirable therefore, which will allow the 
immediate treatment of a patient with a selective antibi- 
otic or antibiotics which excludes the inclusion of inap- 
propriate, unnecessary, and often toxic agents in the 
therapeutic regimen of an infected person. 
The agar diffusion (Kirby-Bauer technique) method 
involves an overnight culture of a urine sample. The 
coloniesof interest are separated out and an inoculum is 
obtained by dilution in trypticase soy broth (TSB), to 
such a concentration that a dense growth is observed. 
The culture turbidity is adjusted to a concentration 
which conforms to a turbidity standard. The standard is 
formed by mixing 0.5 ml of 0.048 M barium chloride 
(1.175% w/v Ba C12-2H20) with 99.5 ml of 0.36 
(NI-I&S04(l% w/v). A sterile cotton swab is soaked in 
the diluted culture, and an agar plate is then streaked in 
four directions to obtain an even and thorough distribu- 
tion of the organisms on the plate. The treated plates are 
dried for 15 minutes at 37" C. Thereafter, antibiotic 
discs are applied to the surface of the agar and pressed 
into place. The plates are then allowed to stand at room 
temperature for 30 minutes and incubated at 37" C. for 
18 to 20 hours. A clearly defined zone will appear 
around an antibiotic disc where no bacterial growth has 
occurred. The zone diameter will vary with the relative 
resistance or susceptibility of the bacterial strain under 
test to the particular antibiotic used. The test must be 
replated for each original bacterial colony of interest. 
The chief disadvantage of this type of test is the time 
The broth dilution (MICBroth Dilution) method of 
determing microbial sensitivity to antimicrobial agents 
involves visual detection of the least amount of antimi- 
crobial agent required to cause complete inhibition of 
10 bacterial growth in a culture medium. In this technique, 
two-fold dilutions of antibiotics are made in a suitable 
culture medium. A control tube containing the culture 
medium, without an antibiotic, is also included for each 
organism tested. The organism is then allowed to grow 
15 to a logarithmic or early stationary phase of growth in 
the medium, and then diluted to  a solution containing 
lo" to los viable units per milliliter. A quantity of the 
cultured medium is then placed in each tube of a series 
containing varying amounts of an antibiotic, and the 
20 tubes are allowed to incubate at 37" C. for 16 to 20 
hours. Thereafter, the end point of the test is deter- 
mined visually, as described above. A disadvantage of 
this technique, in addition to the relatively long time 
required to complete the test is that care must be taken 
25 to recognize that slight amounts of turbidity present 
may be caused by the inoculum itself and not by the 
growth of the organism. 
The agar dilution method of determining microbial 
sensitivity to antimicrobial agents involves the same 
30 process as the broth dilution except that the process is 
modified to include the introduction of nutrient agar to 
the antibiotic dilutions, which become solid, so that a 
spot application of the diluted broth culture will result 
in the growth or no growth of the organisms on the agar 
SUMMARY OF THE INVENTION 
Accordingly, one object of the present invention is to 
provide a rapid method for determining the sensitivity 
Another object of the invention is to provide a 
method of measuring the sensitivity of microbial organ- 
isms present in a physiological fluid to various antimi- 
crobial agents. 
Yet another object of the invention is to provide a 
method of measuring the sensitivity of microbial organ- 
isms present in urine to multiple antimicrobial agents. 
Still another object of the invention is to provide a 
method of measuring the sensitivity of microbial organ- 
50 isms present in a physiological fluid to various antimi- 
crobial agents without isolation of each strain of organ- 
ism present. 
Another object of the invention is to provide a 
method of measuring antimicrobial sensitivity of bac- 
Yet another object of the invention is to provide a 
method of measuring antimicrobial sensitivity of bac- 
teria after determining a quantitated infection. 
Briefly, these and other objects of the invention, as 
60 hereinafter will become more readily apparent, can be 
attained by a method for determining the sensitivity of 
bacteria to antimicrobial agents by measurement of an 
ATP index by the following procedure. First, there 
must be a determination as to whether or not an infec- 
This determination is made by means of a bacterial 
ATP luminescent assay of a physiological fluid sample, 
for example, urine, which is correlated with a bacterial 
5 consumed to determine susceptibility. 
35 surface. 
40 of bacterial organisms to antimicrobial agents. 
45 
55 teria in a routine system for chemical application. 
65 tion exists. 
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count. If the bacterial count is below approximately 3 Pat. Application Ser. No. 555,641, Picciolo et al, now 
X l@CFU/ml for urine, the patient is not normally U.S. Pat. No. 3,971,703. Their disclosures are incorpo- 
considered to have an infection. With respect to blood rated by reference and both of common assignee here- 
almost any count at all would be considered to be an with. It should be understood that these prior inven- 
infection. All specimens should be collected in essen- 5 tions deal only with bacterial ATP assays using a light 
tially sterile fashion. reaction, converting the light reading to an ATP read- 
Assuming there is an infection, another portion Of the ing and, thereafter, correlating the ATP reading with a 
same fluid must be tested with respect to one or more bacteria count. mey con& no d&]aure to 
antibiotics to determine if the dominant bacterial strain the determination of bacterial susceptibility to a given 
or strains are susceptible to the antibiotic or antibiotics 10 &,timicrobid agent, It has previously been hewn to 
achieve a working inoculum and the resulting inoculum approach to determine bacterial susceptibility to antimi- is preincubated. At this point a min ium of three sam- crobial agents but the previous method required the ples are diquoted for one antibiotic under test. While isolation and culturing of each dominant bacterial strain the remaining discussion will relate to the susceptibility 15 found in the physiological fluid sample. The present 
method is less time consuming, time being of the essence testing of a particular fluid vis-a-vis one antibiotic, it should be understood that the same methodology 
would be repeated in order to test a multiplicity of in many cases. The present invention provides a rapid 
antibiotics. The sample to be tested with an antibiotic determination of bacterial susceptibility to one or more 
should now have the antibiotic add&, the remaining 2o antimicrobial agents by recognizing that isolation of 
samples will have an equivalent volume of water various bacteria in a physiological fluid is not required 
added. One sample without antibiotic is immediately to form a meaningful ATP index i.e., all that is required 
assayed for bacterial ATP while the rem-ng one is the determination of whether or not a particular anti- 
sample without antibiotic and the remaining one biotic is generally effective ag&t the dominant back- 
with antibiotic are incubated at about 37’ C. for about 25 rial strains Present in the sample mder test- 
2.5 hours and then they are assayed for bacterial ATP The Process Ofthis invention is generally useful with 
content. All bacterial ATP assays are carried out by respect to any physiological fluid where enough fluid to 
obtaining light readings by reacting bacterial ATP with Perfom the required Steps Can be obtained and the fluid 
a luciferase-luciferin mixture. The assay results, in terms contains a sufficient bacterial concentration to represent 
of light units, are placed in an empirical equation defin- 3o infection. The physiological fluids to which the inven- 
ing an “ATP index” of inhibition Le., an index indicat- tion is particularly applicable are urine, spinal fluid, 
ing whether the bacteria causing the infection are gen- pleural fluid, sputum, blood, acites and milk. The de- 
erally resistant to the antibiotic under test. The equation tailed discussion relates to the use of urine, one of the 
is: easier fluids to work with. When working with blood, 
35 the red and white blood cells need to be first removed, 
for example, by slow centrifugation, since they would 
act as inhibitors in the process. With respect to any 
fluid, the process inhibitors must be removed. With B2 5 is the reading for the sample with the antibiotic 
solvent would have to be used. A2.5 is the reading for the sample without antibiotic for the determina- 
tion of bacterial susceptibility to one or more antibiot- is the reading for the sample without antibiotic its, it was initially required to determine if an infection 
is present. If there is no infection the process is, of It has been determined that an ATP index of greater 45 course, aborted. With each type fluid sample and each than 0.05 is an indication that the dominant bacterial type of collection system used to get the sample, a some- strain or strains present are generally resistant to the what arbitrary level of bacteria count per milliliter antibiotic tested. should be established as a threshold which must be 
DETAILED DESCRIPTION OF THE exceeded for an infection to be considered to exist. With 
PREFERRED EMBODIMENTS 50 urine specimens obtained by common collection meth- 
known in that art. The first requirement for making a therefore, a first st% when the process involves a 
bacterial ATP assay of a sample is to free all non-bac- urine sample, a determination has to be made as tb 
te&l mupes of ATP and ~&ctive]y destroy this ATP, whether or not an infection exists, i.e., whether the 
otherwise the bacterial ATP readings will be inaccu- 55 
rate. Next, the bacterial cells are ruptured to free their When a urine specimen is received, about a 35 ml 
ATP without destruction. A bacterial ATP assay can sample Size  is retained and concentrated, by centrifuga- 
then be w e d  out by reacting the bacterial ATP with tion Or filtration, to remove the liquid or supernatant 
a luciferase-luciferin compound to obtain a light reac- Phase- The Preferred method for accomplishing this 
tion proportional to the ATP present. The light reac- 60 result is to centrifuge at Vm for 15 minutes to 
tion can be converted to a measurement of ATP present obtain a Pellet. The sample and resulting pellet should 
whch, in turn, can be related to a bacterid count. In be kept at a low temperature, about 4“ C., to avoid 
conducting backrial ATP assays for the purposes of bacterial growth. The purpose of this step is to eliminate 
carrying out the instant invention, there is no need to the supernatant phase, which would interfere with bac- 
obtain a bacteria count; only light readings need be 65 terial growth, and obtain a pellet of concentrated bac- 
obtained. One bacterial ATP assay process is disclosed teria (and other solid, particulate matter such as white 
in U.S. Pat. No. 3,745,090 issued to Chappelle et al. An and red blood cells). The speed of the centrifuge should 
improved, more sensitive process, is disclosed in U.S. be sufficient to separate out bacteria from the superna- 
under test. Broth iS added to this second portion to use bacterial ATP assay techniques and the ATP index 
ATP index = (E2 5 - Ad442 5 - Ao) , 
where 
to a thick fluid, such as mucus, a 
after incubation for 2.5 hours. 
after incubation for 2.5 hours; and 
without incubation. 
In the of this 
Basic bacterial ATP assay methodology is now well OdS the generally is 3 x l@cm/ml*  
30*000 milliliter- 
5 
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tant phase but not of such kgni tude as to rupture bac- 
terial cells or remove any bacterial ATP. The volume of 
urine required for the test depends on the number of 
antibiotics to be tested and the concentration of bacteria 
present. A 10 ml urine sample appears to be the mini- 
mum. 
The pellet is now reconstituted by adding a liquid 
growth medium, preferably about 1.75 ml of trypticase 
soy broth (TSB). This is sufftcient to provide two work- 
ing portions; one for immediate determination of bacte- 
rial concentration to defme whether an infetion is pres- 
ent and the other for later antibiotic susceptibility test- 
ing. There is , therefore, a 20-times concentration of 
whatever bacterial concentration was present in the 
original specimen. Probably no less than 1.5 ml should 
be used. The resultant fluid is then vortexed, by hand or 
preferably machine to distribute the pellet in the broth. 
Two portions are then measured out., one for the detec- 
tion assay and one for the antibiotic susceptibility test. 
In general 0.5 ml is used for the detection assay and 
about 1.25 ml is used for the antibiotic susceptibility 
test. The portion used for the antibiotic susceptibility 
test (if an infection is determined to exist) is stored at 
about 4' C. to prevent growth of the bacteria present. 
As with the previously noted centrifuging step tempera- 
ture, 4' C. appears to be an excellent temperature choice 
to prevent bacteria growth. For one thing, the portions 
can not be allowed to go below their freezing point 
because the bacteria will rupture. For another, the por- 
tions can not be allowed to go above a temperature 
whereby the bacteria will significantly multiply or 
change their ATP levels during the period they are 
standing by for use. At this point, the 0.5 ml and 1.25 ml 
portions are processed and standing by for use; the 0.5 
portion is ready for the detection assay and the 1.25 ml 
portion is stored for the later possible antibiotic suscep- 
tibility testing. 
To the 0.5 ml portion a detergent and a hydrolyzing 
enzyme for the ATP (an ATP-ase) is added. The deter- 
gent must be capable of selectively rupturing (lysing) 
non-bacterial cells so that their ATP is made soluble. 
The hydrolyzing enzyme must be capable of hydrolyz- 
ing the ATP when it is made soluble by the detergent. 
One particularly suitable combination is TRITON 
X-100 (TX) for the detergent and apyrase for the en- 
zyme, beiig present prior to and after lysing of the 
non-bacterial cells. More specifically, 0.1 ml of 10 
mg/ml apyrase in 0.03M CaC12 and 0.1 % TX is added 
to the 0.5 ml portion, volume by volume, the CaCl2 
furnishing calcium as a necessary cofactor for the apy- 
The resulting solution is vortexed and a 0.9% NaCl 
weight by volume solution of sterile deinoized water 
added to bring up the volume to wash the sides of the 
tube being used. The criteria for the solution used is that 
it can not be hypotonic or hypertonic to the bacterial 
cells present. The solution is again vortexed and enough 
time allowed to lapse for the apyrase to take effect, the 
TX working immediately. A typical time period is 15 
rase. 
ing a greater bacterial count than actually present. 
Malic acid is added to free the bound ATP, specifically 
1 ml of 0.25 M malic acid, which is prepared from so- 
dium malate and adjusted to a pH of 4.25. The solutuion 
5 is vortexed. If an excessive amount of malic acid is 
added it interferes with the action of the nitric acid to be 
added later. If too little is added, the pH will be insuffi- 
cient to allow desorbtion of ATP. The apyrase hydro- 
lyzes the previously bound ATP during the next step. 
At this stage of the process, the solution is concen- 
trated to remove the liquid phase and, concomitantly, 
the interfering compounds. It is especially important to 
remove the apyrase so that the later acquired bacterial 
ATP is not hydrolyzed. The concentration step is again 
15 centrifuging at So00 rpm for 15 minutes at 4' C. Filtra- 
tion or other concentration techniques may be em- 
An extracting agent is added to rupture the bacterial 
cells thereby to free the bacterial ATP to permit mea- 
20 surement of the bacterial ATP and relate it to  a bacteria 
count. Any extractant may be used which will release 
the bacterial ATP without any substantial hydrolyzing 
or other destruction of the ATP, Le., 0.2 ml 0.1N 
HNO3 le& to operate about 5 minutes. The solution is 
25 now diluted and vortexed to weaken the acid concen- 
tration so that it will not interfere with the later de- 
scribed luciferase-luciferin reaction, Le., the hydrogen 
ion concentration must be reduced or else the acid will 
diminish the light reaction between the ATP present 
30 and the luciferase-luciferin. For this purpose 0.2 ml 
sterile, deionized water may be used, sometimes with 
sodium sulfate in solution which is good for blank light 
level depression when the light level is measured. 
After addition of the above-disclosed water and vor- 
35 texing, the ATP, which is bacterial ATP, is assayed to 
obtain a working estimate of the bacteria count. The 
assay procedure is the same as described in the above- 
identified references which basically involved taking 
the resulting solution with bacterial ATP and reacting it 
40 with a luciferase-luciferin mixture and, thereafter, plac- 
ing the solution into a light-tight chamber of a photome- 
ter. The resulting light reading is equated to an ATP 
reading which in turn, is correlated with a bacteria 
count. The amount of solution required at this point in 
45 the process is a minimum of 0.4 ml which is, in effect, a 
25 times concentration of the original urine sample. If 
the readiig indicates a bacterial count below 3 x 
l@CFU/ml an infection is not normally considered to 
be present and the process would be terminated here, 
50 Le., there would be no testing for antibiotic susceptibil- 
ity. Assuming the reading to be over a 3 x lo"CFU/ml 
bacteria count, the next series of s t e p  is then under- 
taken to determine the bacterial susceptibility to one or 
more antibiotics. 
At this stage, broth is added to the previously stored 
second portion to achieve a working inoculum, The 
second portion is preferably a m i n i u m  of 1.25 ml. The 
object is to achieve a working inoculum size for the 
antibiotic susceptibility test that will provide results 
10 
ployed. 
55 
minutes, however, the t h e  ne&ssary is ultimately de- 60 which correlate well with the traditional Kirby-Bauer 
pendent on ATP present. test. Ideally a IO5 to l@CFU/ml range is desired in the 
The next step in the process is to free membrane 1.25 ml portion. If a marginal infection exists, a mini- 
bound ATP into solution so that it also is available for mum of broth is added so that the portion still has a 
destmction by the already present apyrase. The amount growth medium but only to the point where the portion 
of bound ATP present can be small or large since it is 65 has a 1.5 ml volume. If a heavy infection is present, 
related, to a great extent, to the number of blood cells significant dilution is required to enable the resulting 
present. If the bound ATP were left present in the fluid, solution to have a lo5 to ldCFU/ml bacterial concen- 
it would be counted along with bacterial ATP indicat- tration. 
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The solution is now pre-incubated to get the organ- 
isms present into log phase growth. The generally used 
procedure is to preincubate at 37" C., which simulates 
body temperature. In any event, the time period used 
must be of sufficient duration for log phase growth to 
begin for most bacteria present at whatever temperature 
is employed. A 20' C. to 45' C. temperature range has 
been found suitable. 
After pre-incubation is completed, at least three ali- 
quots of preferably, at least 0.45 ml each are divided 
out. The 0.45 ml figure is related to the normally used 
working volume of urine employed. These three alig- 
uots form the three minimum samples required for anti- 
biotic susceptibility testing of one antibiotic. An antibi- 
otic is added to one sample. To the other two samples 
sterile, dionized water is added to compensate for the 
volume of antibiotic added to the first sample. By 
matching the volume of the antibiotic present, bacterial 
concentration equivalency is maintained at that point to 
maintain testing integrity. In general about 0.05 ml of 
antibiotic or water is added to each sample. If a multiple 
of antibiotics are used, the concentrations are varied to 
achieve the same volume for a working dosage that is 
added to a sample. If this is done, only one additional 
0.45 mi sample is required for each antibiotic under test. 
The amount of antibiotic used is essentially dependent 
on the amount of the urine available. 
At this stage one sample with antibiotic and one sam- 
ple without antibiotic are placed into an incubator, the 
third sample, without antibiotic is immediately assayed 
according to the assay procedure herein before dis- 
closed for infection determination, except that a less 
specific method, i.e., a method eliminating the malic 
acid addition to ultimately destroy bound ATP, may be 
employed. The reason for this is that in this test only 
relative, not absolute levels of bacterial ATP need be 
measured. The other two samples are incubated usually 
for 2.5 hours, to get the organisms into a log growth 
pattern. The incubation again is at 37' C. but can be 
within the range of about 20' C. to 45' C. Some bacteria 
are slow growing and would require additional time to 
achieve log growth. Of course, lower temperature incu- 
bation would also require a longer incubation period. 
Typically, the range is 0.5 to 10 hours. The 2.5 hour 
period at 37' C. is, however, generally sufficient. Upon 
completion of the incubation period, the incubated sam- 
ples are assayed. (Again, there will be more than two 
samples if more than one antibiotic is under test.) The 
assay results on all three samples, in terms of light units, 
are placed into the equation: 
ATP index = (B, - &)/(A, - Ao) 
8 
ent are considered to be resistant the antibiotic for 
which the index is obtained. In terms of clinical prac- 
tice, the result would be interpreted as meaning that the 
antibiotic tested should not be used to cure the infection 
present. 
The invention is further illustrated by the following 
working example which is illustrative of results ob- 
tained with one embodiment of the invention and is 
provided to teach those skilled in the art how to prac- 
tice the invention with respect to one mode contem- 
plated for carrying out the invention. 
EXAMPLE 
(a) A 35 ml urine sample was centrifuged at 8ooo rpm 
for 15 minutes at 4' C. to form a pellet and eliminates 
the liquid phase. 
(b) The pellet was reconstituted by adding 1.75 ml of 
TSB obtain a 20 times concentration to the original 
(c) The solution was vortexed to distribute the pellet 
in the broth. 
(d) Two portions of the solution were measured out, 
the first portion being 0.5 ml and the second portibn 
20 sample. 
25 being 1.25 ml. 
(e) The second portion was stored at 4' C. 
The following relates to processing of the first por- 
0.1 ml of a IO mg/ml concentration of apyrase in 
30 0.03M CaC12 and 0.1% TX, was added per 0.5 ml of the 
tion. 
first portion. 
(g) The portion was vortexed. 
(h) 5 ml of 0.9% weight by volume d i e  solution of 
35 sterile, deionized water was added to the first portion. 
(i) The portion was vortexed and allowed to stand for 
15 minutes. 
6) 1 ml of 0.25 M malic acid at a pH of 4.5 was added 
to the portion. 
(k) The portion was centrifuged at 8000 rpm for I5 
minutes at 4' C. to form a pellet. 
(I) 0.2 ml 0.1 N HNO3 was added to the portion 
which was allowed to stand for 5 minutes to lyse the 
bacterial cells. 
(m) The portion was diluted with 0.2 ml of a sterile, 
deionized water or with a 0.15 M sodium sulfate solu- 
tion. 
(n) The sample was then assayed for ATP by reacting 
it with a luciferase-luciferin solution to determine if the 
bacterial count is at least 3 x I O ~ C F U / ~ .  
Assuming the infection exceeds 3 X lO'kl?U/ml the 
40 
45 
where process is continued with the second portion 
(0) To the second portion enough TSB was added in 
order to achieve a working inoculum of form between 
@) ne portion was pre-incubated for 4 hours at 370 
B, represents a light reading for a sample treated with 
antibiotic and allowed to incubate for a time "t"; 
A, represents a light reading for a sample not treated 55 105 and 106CFU/ml. 
with antibiotic and allowed to incubate for a time 
Y'; and 
with antibiotic and not allowed to incubate taken at M) three samples. 
time zero. 
C. in order to get the bacteria into log phase growth. 
A 0  represents a light for a -PIe not treated (9) Three 0.45 ml aliquots were divided out to form 
(Alternatively the aliquots may be developed prior to 
(r) To  one sample was added 0.05 ml of antibiotic 
(s) To other two samples was added 0.05 ml each of 
(t) One of the two samples without antibiotic was 
immediately assayed for ATP in terms of light units 
without bothering to destroy bound ATP. 
The ATP index can also be determined according to incubation.) 
the equation: 
ATP index = (log B, - log Ao)/(log A, - log Ao) 
65 sterile, deionized water. 
If the ATP index is equal to or greater than 0.05 in the 
former equation or greater or equal to 0.25 in the latter 
equation the dominant bacterial strains generally pres- 
4.132,599 
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(u) Tht: remaining two samples were incribated for 
2.5 hours ar 37” C and, thereafter, assayed in a fashion 
similar to the assay in step 3”. 
Note: The assays required in “(t)” and ”(u)” can be 
any ATP assay which may or may not first destroy the 
bound ATP. One possible assay procedure is: 
(1) add 0.1 ml of 10 mg apyrase/ml, 0.03 M CaC12 
plus 0.6% TX-100 to the sample to be assayed; 
(2) vortex and allow to stand for 15 minutes; 
(3) add 0.1 ml 1.5 N HNO3; 
(4) vortex and allow to stand for 15 minutes; 
(5) add 4.3 ml H20 or 0.085 M NazS04; 
(6) vortex; and 
(7) assay by injecting into a luciferaseluciferin mix- 
(v) The assay results were placed into the equation: 
ture. 
ATP index = (B25 - Aa)/(A2.5 - Ao) 
where 
Bz.5 represents a light reading for the sample treated 
with antibiotic and allowed to incubate for 2.5 
horn; 
A2.5 represents a light reading for the sample not 
treated with antibiotic and allowed to incubate for 
2.5 nours; and 
& represents a light reading for a sample not treated 
with antibiotic and not allowed to incubate, taken 
at time zero. 
(w) An ATP index of 0.05 or greater would indicate 
that the dominant bacterial strains present are generally 
resistant to the antibiotic under test and that the antibi- 
otic should not be used in treatment of the infection; an 
ATP index of less than 0.05 would indicate that the 
dominant bacterial strains present are generally suscep- 
tible to the antibiotic under test and that the antibiotic 
could be used in treatment of the infection. 
The method of the instant invention, as disclosed 
herein, results in an improved method of determining 
bacterial susceptibility to antimicrobial agents, espe- 
cially in a clinical environment. The method is, of 
course, also adaptable to a laboratory environment. 
The method is not only suitable for use with urine 
samples, but is also adaptable to the determination of 
bacterial suscebtibilitv to antimicrobial ascents where 
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the bacteria is carried in other physiologi&l fluids. 
The principles, preferred embodiments and modes of 
operation of the present invention have been described 
in the foregoing specification. However, the invention 
which is intended to be protected herein, is not to  be 
construed as limited to the particulars disclosed since 50 
these are to be regarded as illustrative rather than re- 
strictive. Variations and changes may be made by those 
skilled in the art without departing from the spirit of the 
present invention. 
45 
We claim: 55 
1. A method for determining the general susceptibil- 
ity of bacteria constituting a quantitated infection in a 
physiological fluid sample to antimicrobial agents with- 
out isolation of any individual bacterial strains that may 
be present by measurement of an ATP index indicating 60 
susceptibility, which comprises: 
forming a solid containing bacteria by eliminating the 
liquid phase from the physiological fluid sample; 
reconstituting the sample to a liquid by adding an 
aqueous growth medium to achieve a working 65 
inoculum; 
pre-incubating the treated sample containing all the 
bacterial strains present in the physiological fluid 
10 
to achieve log growth and dividing the sample into 
at least three p ~ t i o n s ;  
adding sterile water to two portions and an antibiotic 
to each remaining portion and assaying one portion 
of said two portions without antibiotic for ATP; 
incubating all other portions for a time sufticient for 
the antibiotic or antibiotics to take effect against 
the bacteria present, assuming the antibiotic to be 
effective; 
assaying said all other portions for ATP; and deter- 
mining the ATP index to indicate sensitivity of the 
bacteria to the antibiotic according to the formula 
ATP index = (L?, - A&A, - Ao). 
where 
Bt represents an ATP assay reading for the portion 
or portions treated with an antibiotic and al- 
lowed to incubate; 
AI represents an ATP assay reading for the portion 
not treated with antibiotic and allowed to incu- 
bate; and 
& represents an ATP assay reading for the portion 
not treated with antibiotic and not allowed to 
incubate. 
2. A method for determining the general susceptibil- 
ity of bacteria constituting a possible infection in a urine 
sample to antimicrobial agents without isolation of any 
individual bacterial strains that may be present by mea- 
surement of an ATP index indicating susceptibility, 
which comprises: 
forming a solid containing bacterial and non-bacterial 
cells by eliminating the liquid phase from the urine 
sample; 
reconstituting the sample to a liquid by adding a 
growth medium; 
measuring out first and second portions; 
storing the second portion under conditions prevent- 
thereafter treating the first portion by: 
adding a hydrolyzing enzyme capable of hydrolyzing 
ATP and a detergent capable of rupturing non-bac- 
terial cells; 
adding an agent capable of freeing bound ATP from 
non-bacterial cells; 
forming a solid containing bacterial cells; 
rupturing the bacterial ells; 
assaying the treated first portion for ATP to deter- 
mine the presence of an infection; 
adding an aqueous growth medium to the second 
portion to achieve a working inoculum; 
pre-incubating the treated second portion containing 
all the bacterial strains present in the urine sample 
to achieve log growth and dividing the second 
portion into at least three samples; 
adding sterile water to two samples and an antibiotic 
to each remaining sample and assaying one sample 
of said two samples without antibiotic for ATP 
incubating the all other samples for a time suficient 
for the antibiotic or antibiotics to take effect against 
the bacteria present, assuming the antibiotic to be 
effective; 
ing significant bacterial growth; 
assaying said all other samples for ATP; and 
determining the ATP index to indicate sensitivity of 
the bacteria to the antibiotic according to the for- 
mula: 
11 
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ATP index = (Bt -- Ao), 
where 
Bl represents an ATP assay reading for the sample 
or samples treated with an antibiotic and allowed 5 
to incubate; by centrifugation. 
A, represents an ATP assay reading for the sample 
not treated with antibiotic and allowed to incu- 
bate; and 
not treated with antibiotic and not allowed to 
incubate. 
3. A method for determining the general susceptibil- 
ity of bacteria constituting a possible infection in a phys- 
iological fluid to antimicrobial agents without isolation 15 
of particular bacteria by measurement of an ATP index 
indicating susceptibility, which comprises: 
assaying a portion of the fluid for ATP to determine 
the existence of an infection; and 
dividing a remaining portion of the fluid into at least 20 
three samples before or after pre-incubation to 
have bateria which are all those strains present in 
the untreated physiological fluid present enter log 
phase growth; 
to each remaining sample and assaying one sample 
of said two samples without antibiotic for ATP; 
incubating all other samples for period suficient for 
significant bacterial growth in the absence of an 
effective antibiotic; 
4. The method of claim 1 wherein said bacteria are 
derived from a body fluid selected from the group con- 
sisting of urine, ascites, lymph fluid, plasma, blood, 
spinal fluid, saliva and mucus. 
5, The method of claim 1 wherein said solid is formed 
6. The method of claim 1 wherein said growth me- 
7. The method of claim 1 wherein the working inocu- 
8. The method of claim 1 wherein pre-incubation is 
for about 6 hour at about 37" C .  
9. The method of claim 1 wherein incubation is for 
about 2.5 hours at about 37' C. 
10. The method of claim 1 wherein all ATP assays are 
light readings. 
11. The method of claim 2 wherein the solid is a pellet 
formed from the urine sample by centrifuging at about 
8ooO rpm for about 15 minutes at 4" C. 
12. The method of claim 2 wherein the solid is recon- 
stituted by adding sufficient trypticase soy broth to 
obtain about a twenty-times concentration of the urine 
sample. 
13. The method of claim 2 wherein said first and 
adding sterile water to two samples and an antibiotic 25 second portions are at least about 0.5 rnl and 1.25 ml, 
14. The method of claim 2 wherein the second por- 
15. The method of claim 2 wherein the hydrolyzing 
3 0  enzyme and detergent are apyrase and octylphenoxyl 
16. The method of claim 2 wherein the agent capable 
17. The method of claim 2 wherein the.solid contain- 
35 ing bacterial cells is a pellet formed by centrifuging at 
about So00 rpm for about 15 minutes at about 4' C. 
18. The method of claim 2 wherein the bacterial cells 
are ruptured by the addition of nitric acid. 
19. The method of claim 2 wherein trypticase soy 
or samples treated with an antibiotic and allowed 40 broth is added to the second portion to achieve a work- 
to incubate; ing inoculum of from about IO5 to lo6 CFU/ml. 
A, represents an ATP assay reading for the sample 20. The method of claim 2 wherein pre-incubation of 
not treated with antibiotic and allowed to incu- the treated second portion is for about 0.5 hours and at 
bate; and about 37" C. 
A,, represents an ATP assay reading for the sample 45 21. The method of claim 2 wherein incubation of the 
not treated with antibiotic and not allowed to 
incubate. 
dium is tryptic= SOY broth. 
&represents an ATP assay reading for the sample 10 lum is from between 10s and 106 CFU/ml. 
respectively. 
tion is stored at about 4' C. 
assaying said all other samples for ATP; and 
determining the ATP index to indicate sensitivity of 
the bacteria to the antibiotic according to the for- 
mula: 
ATP index = (B, -- Ao), 
wherein 
B, represents an ATP assay reading for the sample 
plyethoxyethanol, respectively. 
Of freeing bound ATP is malic acid. 
samples is for about 2.5 hours and at about 37" C .  
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